Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry

ConclusionThe AGAMENON registry suggests that subjects with limited metastatic disease, selected on a clinical basis, can benefit from early surgeries. Prospective trials are needed to confirm these data.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research